Please login to the form below

Not currently logged in
Email:
Password:

Caligor Rx appoints Michael Dallmann as director of strategic planning

He brings experience from Cubist Pharmaceuticals and Peninsula Pharmaceuticals

New Jersey-based Caligor Rx has named Michal Dallman to the newly-created role of as director of strategic planning.

In this position he will be responsible for developing and driving the drug sourcing company's portfolio, including its comparator programmes.

Michael Dallmann: “Through its comparator programmes, Caligor has established an outstanding global reputation marked by the depth of its regulatory expertise, the strength of its relationships with manufacturers and suppliers and the quality of its values. 

“I am delighted to join Caligor and look forward to helping to shape and execute the company's long-term strategic objectives … it's a privilege to be part of this growing organisation.”

Dallmann - who has over two decades of pharmaceutical experience - moves to Caligor from Cubist Pharmaceuticals, which he joined as director of global clinical trial supply in 2013.

Prior to this he also served as associate director of research and development project planning for Peninsula Pharmaceuticals, a Johnson & Johnson company.

Tammy Bishop, Caligor managing director, said: “Mike is an experienced leader who brings the ideal complement of strategic skills to support our growing business.

“His international product development background and the strong relationships he has established over more than two decades in the life sciences industry will serve us well as we continue to expand our services across Europe and Asia.”


5th January 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics